Abstract
Purpose : Pentoxifylline (PTX), a methylxanthine phosphodiesterase inhibitor reduces superoxide anions responsible for DNA apoptosis. The null hypothesis was that PTX was equally effective in reducing damage to specific cell genes. The objective was to determine the DNA integrity of the BRCA1 tumor suppressor gene and the c-myc proto-oncogene after PTX.
Methods : Sperm (64 samples, 4 patients) were preincubated in either 0 (control) or 3.6 mM PTX (30 min), washed and incubated for 4 h at either 37 or 40°C heat shock activation. Single primer polymerase chain reactions (PCR) were carried out on lysed sperm targeting either BRCA1 exon 11 or c-myc exon 1. Control single-stranded DNA (ssDNA) were stained with 9 μM Hoechst 33342 (blue) while PTX-treated ssDNA were stained with SYBR Gold (green). Nytran membrane discs with control ssDNA were hybridized to PTX-derived ssDNA. Fluorescent images stored in a microarray design were analyzed using ANOVA and Students' t-test for (P < 0.05) significance.
Results : BRCA1 integrity was higher with PTX pretreatment (93.3 + 10.4 vs. control 50.5 + 9.2; mean + SEM). In contrast, there was no difference in c-myc integrity (56.8 + 9.0 vs. 41.7 + 6.4). Sense or antisense primers gave similar DNA fragmentation results.
Conclusions : The data showed PTX pretreatment protected BRCA1 but not c-myc suggesting that PTX did not equally protect different cell genes. A possible explanation was that proto-oncogenes had more fragile sites. The study involved the DNA disc chip assay to assess separate PCR-amplified sense and antisense strands. The results suggested that both strands were equally affected by PTX pretreatment.
Similar content being viewed by others
REFERENCES
Stefanovich V: Effect of 3,7-dimethyl-1-(5-oxohexyl)-xanthine and 1-hexyl-3,7-dimethyl-xanthine on cyclic AMP phosphodiesterase of the human umbilical cord vessels. Res Commun Chem Pathol Pharmacol 1973;5:655-662
Yovich JL: Pentoxifylline: Actions and applications in assisted reproduction. Hum Reprod 1993;8:1786-1791
Van Furth AM, Verhard-Seijmonsbergen EM, van Furth R, Langermans JA: Effect of lisofylline and pentoxifylline on the bacterial-stimulated production of TNF-alpha, IL-beta IL-10 by human leucocytes. Immunology 1997;91:193-196
Gavella M, Lipovac V, Marotti T: Effect of pentoxifylline on superoxide anion production by human sperm. Int J Androl 1991;14:320-327
Bessler H, GilGal R, Djaldetti M, Zahavi I: Effect of pentoxifylline on the phagocytic activity, cAMP levels, and superoxide anion production by monocytes and polymorphonuclear cells. J Leukoc Biol 1986;40:747-754
Mundle SD, Reza S, Ali A, Mativi Y, Shetty V, Venugopal P, Gregory SA, Raza A: Correlation of tumor necrosis factor alpha (TNF alpha) with high caspase 3-like activity in myelodysplastic syndromes. Cancer Lett 1999;140:201-207
Peeker R, Abramsson L, Marklund SL: Superoxide dismutase isoenzymes in human seminal plasma and spermatozoa. Mol Hum Reprod 1997;3:1061-1066
Aitken RJ, Harkiss D, Buckingham DW: Analysis of lipid peroxidation mechanisms in human spermatozoa. Mol Reprod Dev 1993;35:302-315
Twigg J, Fulton N, Gomez E, Irvine DS, Aitken RJ: Analysis of the impact of intracellular reactive oxygen species generation on the structural and functional integrity of human spermatozoa: Lipid peroxidation,DNAfragmentation and effectiveness of antioxidants. Hum Reprod 1998;13:1429-1436
Lopes S, Jurisicova A, Sun JG, Casper RF: Reactive oxygen species: Potential cause forDNAfragmentation in human spermatozoa. Hum Reprod 1998;13:896-900
Pang SC, Chan PJ, Lu A: Effects of pentoxifylline on sperm motility and hyperactivation in normozoospermic and normokinetic semen. Fertil Steril 1993;60:336-343
Alvarez JG, Minaretzis D, Barrett CB, Mortola JF, Thompson IE: The sperm stress test: A novel test that predicts pregnancy in assisted reproductive technologies. Fertil Steril 1996;65:400-405
Smith TM, Lee MK, Szabo CI, Jerome N, McEuen M, Taylor M, Hood L, King MC: Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. Genome Res 1996;6:1029-1049
Cole MD: The myc oncogene: Its role in transformation and differentiation. Annu Rev Genet 1986;20:361-384
World Health Organization:WHOLaboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus Interaction, 4th ed. Cambridge, UK, The Press Syndicate of the University of Cambridge, 1999, pp. 19-23, 60-61
Yunis JJ, Soreng AL, Bowe AE: Fragile sites are targets of diverse mutagens and carcinogens. Oncogene 1987;1:59-69
Naz RK, Kumar G, Minhas BS: Expression and role of c-myc protooncogene in murine preimplantation embryonic development. J Assist Reprod Genet 1994;11:208-216
Adamson ED: Oncogenes in development. Development 1987;99:449-471
Duffy MJ: Cellular oncogenes and suppressor genes as prognostic markers in cancer. Clin Biochem 1993;26:439-447
Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC: Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990;250:1684-1689
Black DM, Solomon E: The search for the familial breast/ovarian cancer gene. Trends Genet 1993;9:22-26
Narod SA, Feunteun J, Lynch HT, Watson P, Conway T, Lynch J, Lenoir GM: Familial breast-ovarian cancer locus on chromosome 17q12-q23. Lancet 1991;338:82-83
Easton DF, Ford D, Bishop DT: Breast and ovarian cancer incidence in BRCA1-mutation carriers: Breast Cancer Linkage Consortium. Am J Hum Genet 1995;56:265-271
Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu O, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Ghulami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266: 66-71
Steichen-Gersdorf E, Gallion HH, Ford D, Girodet C, Easton DF, DiCioccio RA, Evans G, Ponder MA, Pye C, Mazoyer S, Noguchi T, Karengueven F, Sobol H, Hardouin A, Bignon Y-J, Piver MS, Smith SA, Ponder BAJ: Familial site-specific ovarian cancer is linked to BRCA1 on 17q12-21. Am J Hum Genet 1994;55:870-875
Gudas JM, Nguyen H, Li T, Cowan KH: Hormone dependent regulation of BRCA1 in human breast cancer cells. Cancer Res 1995;55:4561-4565
Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE: Risks of cancer in BRCA1-mutation carriers: Breast Cancer Linkage Consortium. Lancet 1994;343:692-695
Belloc F, Jaloustre C, Dumain P, Lacombe F, Lenoble M, Boisseau MR: Effect of pentoxifylline on apoptosis of cultured cells. J Cardiovasc Pharmacol 1995;25(Suppl 2):s71-s74
Kallioniemi A, Kallioniemi O-P, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992;258:818-821
Schena M, Shalon D, Davis RW, Brown PO: Quantitative monitoring of gene expression patterns with a complementaryDNA microarray. Science 1995;270:467-470
Southern EM: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975;98:503-517
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maxwell, D.T., Jacobson, J.D., King, A. et al. Effect of Pentoxifylline on Tumor Suppressor and Proto-Oncogene Apoptosis in Sperm. J Assist Reprod Genet 19, 279–283 (2002). https://doi.org/10.1023/A:1015725230011
Issue Date:
DOI: https://doi.org/10.1023/A:1015725230011